Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia

類似資料

• Quantifying the Survival Benefit for Allogeneic Stem Cell Transplantation in Relapsed Acute Myeloid Leukemia
  著者:: Armistead, Paul M., 等
  出版事項: (2009)
• Allogeneic Stem Cell Transplantation for CML Resistant to Tyrosine Kinase Inhibitors
  著者:: Champlin, Richard, 等
  出版事項: (2011)
• Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
  著者:: DAI, ZHIMING, 等
  出版事項: (2016)
• Myeloablative reduced-toxicity IV busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life
  著者:: Alatrash, Gheath, 等
  出版事項: (2011)
• Low-Dose Azacitidine After Allogeneic Stem Cell Transplantation for Acute Leukemia
  著者:: Jabbour, Elias, 等
  出版事項: (2009)